Metropolitan Life Insurance Company (MetLife)’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,447
| Closed | -$152K | – | 2360 |
|
|
2023
Q4 | $152K | Buy |
6,447
+779
| +14% | +$18.4K | 0.01% | 870 |
|
|
2023
Q3 | $84.5K | Buy |
5,668
+300
| +6% | +$4.47K | ﹤0.01% | 1102 |
|
|
2023
Q2 | $58.8K | Buy |
+5,368
| New | +$58.8K | ﹤0.01% | 1326 |
|
|
2022
Q2 | – | Sell |
-6,132
| Closed | -$19.1K | – | 2453 |
|
|
2022
Q1 | $19.1K | Buy |
+6,132
| New | +$19.1K | ﹤0.01% | 2121 |
|
|
2021
Q4 | – | Sell |
-20,041
| Closed | -$73.2K | – | 2845 |
|
|
2021
Q3 | $73.2K | Buy |
+20,041
| New | +$73.2K | ﹤0.01% | 2685 |
|
|
2021
Q2 | – | Sell |
-22,403
| Closed | -$102K | – | 2910 |
|
|
2021
Q1 | $102K | Buy |
22,403
+11,789
| +111% | +$53.5K | ﹤0.01% | 2421 |
|
|
2020
Q4 | $60.9K | Sell |
10,614
-4,257
| -29% | -$24.4K | ﹤0.01% | 2456 |
|
|
2020
Q3 | $108K | Sell |
14,871
-9,202
| -38% | -$66.6K | ﹤0.01% | 2170 |
|
|
2020
Q2 | $84K | Buy |
+24,073
| New | +$84K | ﹤0.01% | 2358 |
|
|
2019
Q4 | – | Sell |
-20,599
| Closed | -$105K | – | 2573 |
|
|
2019
Q3 | $105K | Buy |
20,599
+699
| +4% | +$3.58K | ﹤0.01% | 2275 |
|
|
2019
Q2 | $142K | Hold |
19,900
| – | – | ﹤0.01% | 2118 |
|
|
2019
Q1 | $264K | Hold |
19,900
| – | – | ﹤0.01% | 1710 |
|
|
2018
Q4 | $157K | Hold |
19,900
| – | – | ﹤0.01% | 1968 |
|
|
2018
Q3 | $220K | Hold |
19,900
| – | – | ﹤0.01% | 1945 |
|
|
2018
Q2 | $267K | Buy |
+19,900
| New | +$267K | ﹤0.01% | 1748 |
|